It is to remark that in non-hematopoietic cells TCPTP is also a demonstrated regulator of interferon signals, and its deficiency equally promotes the expression of Class I MHC and decreases their resistance of tumor to anti-PD1 immunotherapy rendering them more susceptible to the action of CD8 T cells (90). The gene discussed is CD8A; the disease is neoplasm.